Sustained Virological Response after 8-Week Treatment of Simeprevir with Peginterferon α-2a plus Ribavirin in a Japanese Female with Hepatitis C Virus Genotype 1b and IL28B Minor Genotype

Direct-acting antivirals with or without peginterferon α (PEG-IFN α) plus ribavirin are now available for the treatment of hepatitis C virus (HCV) infection. Direct-acting antivirals are potent inhibitors of HCV replication, but some of them occasionally possess serious adverse events. We experience...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, Tatsuo, Nakamura, Masato, Sasaki, Reina, Yasui, Shin, Nakamoto, Shingo, Haga, Yuki, Jiang, Xia, Wu, Shuang, Tawada, Akinobu, Arai, Makoto, Imazeki, Fumio, Yokosuka, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: July, 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520186/
https://www.ncbi.nlm.nih.gov/pubmed/26269697
http://dx.doi.org/10.1159/000437138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520186/
https://www.ncbi.nlm.nih.gov/pubmed/26269697
http://dx.doi.org/10.1159/000437138

Ejemplares similares